Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics-Reference-Cited by-同舟云学术

Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics

Published:2015-01-20 Issue:5 Volume:24 Page:673-687
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Arrondeau Jennifer,Huillard Olivier,Tlemsani Camille,Cessot Anatole,Boudou-Rouquette Pascaline,Blanchet Benoit,Thomas-Schoemann Audrey,Vidal Michel,Tigaud Jean-Marie,Durand Jean-Philippe,Alexandre Jerome,Goldwasser Francois

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543784.2015.1005736

Reference113 articles.

1. The PDGF family: four gene products form five dimeric isoforms

2. Chromosomal Location, Exon Structure, and Vascular Expression Patterns of the Human PDGFC and PDGFD Genes

3. Role of platelet-derived growth factors in physiology and medicine

4. Three Isoforms of Platelet-Derived Growth Factors All Have the Capability to Induce Angiogenesis in Vivo.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the C-Terminal Domain Small Phosphatase 1;Life;2020-05-08

2. Innovative Strategies Targeting the Neovascularization of Solid Tumor;BIOMED HEALTH RES;2019

3. Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events;Respiration;2018-12-13

4. Recent advances in anti-angiogenic nanomedicines for cancer therapy;Nanoscale;2018

5. H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers;Acta Neuropathologica;2017-04-11